WIB is organizing an evening of panels and networking focused on the journey from scientific discovery to market success. The event brings together biotech founders, innovators, and investors to explore fundraising strategies, commercialization pathways, and real-world insights shaping the future of health.
LongeVC managing partner Aurora Griffin will join the fundraising and founder panel alongside Katherine Hill Ritchie from TEDCO. Other panelists include Dr. Martha Sklavos (Aloe Therapeutics) and Dr. Sadiye A. Rieder (Amgen) on science-to-commercialization strategies, as well as founder perspectives from Sheila Corcoran (Evizia) and Donna Edmonds (BRAINBox Solutions). The event will be moderated by Nancy Guida, managing director at KPMG. Join the event on October 10 at KPMG office in Tysons Corner.
More information and registration here.
LongeVC managing partner Aurora Griffin will join the fundraising and founder panel alongside Katherine Hill Ritchie from TEDCO. Other panelists include Dr. Martha Sklavos (Aloe Therapeutics) and Dr. Sadiye A. Rieder (Amgen) on science-to-commercialization strategies, as well as founder perspectives from Sheila Corcoran (Evizia) and Donna Edmonds (BRAINBox Solutions). The event will be moderated by Nancy Guida, managing director at KPMG. Join the event on October 10 at KPMG office in Tysons Corner.
More information and registration here.